Inhibition of Aminopeptidase N (AP-N) and Urokinase-Type Plasminogen Activator (uPA) by Zinc Suppresses the Invasion Activity in Human Urological Cancer Cells.
- 1 January 2001
- journal article
- Published by Pharmaceutical Society of Japan in Biological & Pharmaceutical Bulletin
- Vol. 24 (3) , 226-230
- https://doi.org/10.1248/bpb.24.226
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 20 references indexed in Scilit:
- ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigsInflammation Research, 2000
- Immunoelectron microscopic single and double labelling of aminopeptidase N (CD 13) and dipeptidyl peptidase IV (CD 26)Acta Histochemica, 1996
- A mouse aminopeptidase N is a marker for antigen‐presenting cells and appears to be co‐expressed with major histocompatibility complex class II moleculesEuropean Journal of Immunology, 1993
- Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEVNature, 1992
- Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin)Clinical & Experimental Metastasis, 1992
- The role of urokinase-type plasminogen activator in aggressive tumor cell behaviorCancer and Metastasis Reviews, 1990
- Control of cell locomotion: perturbation with an antibody directed against specific glycoproteinsCell, 1985
- A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.The Journal of cell biology, 1985
- Zinc and the steroid endocrinology of the human prostateThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- ZINC REQUIREMENT FOR DNA REPLICATION IN STIMULATED HUMAN LYMPHOCYTESThe Journal of cell biology, 1973